Microarrays: Company Announcements

GenTel BioSciences announced in March that it acquired GlaxoSmithKline’s protein chip platform assets. Affymetrix launched the Collaborations in Cancer Research Program, an alliance with 30 European cancer researchers. Later this year, the Program will be expanded to North America and Japan. In April, Affymetrix and NuGEN Technologies announced a comarketing agreement for NuGEN’s WT-Ovation FFPE (Formalin-Fixed Paraffin-Embedded) System for analyzing tissue samples inaccessible by traditional RNA amplification methods. Affymetrix’s Clinical Services Laboratory passed California’s survey for CLIA (Clinical Laboratory Improvement Amendments) certification in April for molecular diagnostic patient and clinical trial testing services. Agencourt Bioscience, a Beckman Coulter subsidiary, NuGEN and the Affymetrix Clinical Service Laboratory are offering a service for automated isolation and target preparation of RNA from whole blood samples. In April, Agilent named Cogenics, a division of Clinical Data, as its first Certified Microarray Service Provider for its microRNA microarrays. Agilent and Gene Logic partnered for joint systems-based R&D projects utilizing their respective biorepository of tissue samples and microarray workflow solutions. Lumera and the Medical University of South Carolina plan to develop an antibody array to measure the levels and modifications of patient mitochondrial proteins. Arrayjet appointed BioMicro Systems its exclusive US distributor.

< | >